Skip to main content

Table 4 HBV-DNA conversion rate and reactivation rate at 2 months, 4 months, and 6 months in the three groups

From: TACE versus TACE + entecavir versus TACE + tenofovir in the treatment of HBV associated hepatocellular carcinoma

 

Group

Chi-square test (p-value)

  

Control group

ETV group

TDF group

Pearson Chi-Square

DNA conversion rate

2 months

2.2%

23.7%

31.3%

0.003

4 months

3.5%

41.2%

45.8%

6 months

6.4%

62.9%

71.2%

DNA reactivation rate

2 months

22.6%

8.7%

7.9%

0.001

4 months

56.3%

10.1%

8.2%

6 months

61.1%

11.3%

10.4%